You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 421 A first-in-human (FIH) phase I/IIa clinical trial assessing a ribonucleic acid lipoplex (RNA-LPX) encoding shared tumor antigens for immunotherapy of prostate cancer; preliminary analysis of PRO-MERIT

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
421 A first-in-human (FIH) phase I/IIa clinical trial assessing a ribonucleic acid lipoplex (RNA-LPX) encoding shared tumor antigens for immunotherapy of prostate cancer; preliminary analysis of PRO-MERIT
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to October 2024

AbstractFullPdf
Nov 2021440026
Dec 2021256045
Jan 2022266053
Feb 2022214028
Mar 2022312026
Apr 2022170019
May 2022254047
Jun 2022180030
Jul 2022260030
Aug 2022204028
Sep 2022138025
Oct 2022210028
Nov 2022218024
Dec 2022152022
Jan 2023238023
Feb 2023276020
Mar 2023204013
Apr 2023220027
May 2023174014
Jun 2023190036
Jul 2023214026
Aug 2023248028
Sep 2023190011
Oct 2023174014
Nov 2023198022
Dec 2023136010
Jan 2024114021
Feb 2024308022
Mar 2024350030
Apr 2024332037
May 2024250025
Jun 2024268020
Jul 2024308034
Aug 2024336042
Sep 20243000107
Oct 20242560113
Total855801126